Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF DECEMBER 05, 2022 SAM #7675
SPECIAL NOTICE

66 -- High Throughput Sequencing Reagents and Positive Controls

Notice Date
12/3/2022 9:39:23 AM
 
Notice Type
Special Notice
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
NAVAL MEDICAL LOGISTICS COMMAND FORT DETRICK MD 21702-9203 USA
 
ZIP Code
21702-9203
 
Response Due
12/15/2022 11:00:00 AM
 
Archive Date
12/16/2022
 
Point of Contact
Marchaunda L. Tiller, Phone: 3016193023
 
E-Mail Address
marchaunda.l.tiller.civ@health.mil
(marchaunda.l.tiller.civ@health.mil)
 
Small Business Set-Aside
HZC Historically Underutilized Business (HUBZone) Set-Aside (FAR 19.13)
 
Description
The Naval Medical Readiness Logistics Command (NMRLC) intends to negotiate a single-award Indefinite Delivery Indefinite Quantity (IDIQ) type contract on a sole source basis (in accordance with FAR Part 13.106-1(b)). The proposed source is the Illumina Inc., 5200 Illumina Way, San Diego, CA 92122-4616. This requirement is for nucleic acid sequencing reagents and positive controls for Illumina sequencers MiSeq, iSeq, NextSeq and NovaSeq6000 sequencing instruments. These systems are designed to multiplex samples, meaning multiple samples are sequenced on a single instrument at the same time, greatly increasing the efficiency of the instrument and technician time and greatly increasing the number of samples that can be sequenced. NMRC-BDRD�s mission requires the rapid, efficient genomic characterization of biological threats to US military personnel, therefore these High Throughput Sequencing systems, which are the industry leader in the workflow requirement, need to be utilized and are the DoD-accepted standard for HTS. HTS are routinely used as needed, during the three-year ordering period for Naval Medical Research Center (NMRC), Biological Defense Research Directorate (BDRD), Fort Detrick, Maryland. Illumina Inc. is the sole manufacturer of the MiSeq, iSeq, NextSeq and NovaSeq6000 sequencing instruments routinely used at NMRC-BDRD. These instruments can only utilize patented nucleic acid sequencing reagents produced by the Original Equipment Manufacturer (OEM) Illumina Inc. The Illumina systems utilize technology that generates very accurate data, greater than 99.9% accuracy, which no other system can approach.� This accuracy is needed to identify specific mutations that can affect countermeasures used by US military personnel to detect and treat the pathogen.�� �Based on the above information, the sequencing instruments are only provided by Illumina, Inc. See attachment (NOI-High Throughput Sequencing Reagents and Positive Controls) for Sequencing Reagents list.� Specific deliveries will be outlined in a delivery order with shipments made to Fort Detrick Maryland. This acquisition is being conducted under FAR Parts 12, 13.5 and 15. The intended procurement will be classified under North American Industry Classification System (NAICS) 334516 with a� Size Standard of 1000. � This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement.� However, respondents shall have the capability of providing sufficient number of HTS kits to accommodate approximate 26 tests per month for a period of up to three years.� All capability statements received by the due date of this notice will be considered by the Government. Capability statements shall not exceed two (8.5 x 11 inch) pages, recommend using a Times New Roman font size 11-point or 12-point font.� A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source procurement. Capability statements are due by 1600 Local Time, December 15, 2022. Capability statements shall be submitted by email ONLY as a Microsoft Word or Adobe PDF attachment to the following e-mail address: marchaunda.l.tiller.civ@health.mil. No phone calls will be accepted.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/079926f19e6a4f13962f22d08b287b6e/view)
 
Place of Performance
Address: Frederick, MD 21702, USA
Zip Code: 21702
Country: USA
 
Record
SN06534210-F 20221205/221204211357 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.